» Articles » PMID: 11160154

Fibroblast-like Synoviocytes Support B-cell Pseudoemperipolesis Via a Stromal Cell-derived Factor-1- and CD106 (VCAM-1)-dependent Mechanism

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2001 Feb 13
PMID 11160154
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

B-cell accumulation and formation of ectopic germinal centers are characteristic changes in the diseased joints of patients with rheumatoid arthritis (RA). Earlier studies suggested that interactions between B lymphocytes and specialized synovial "nurse-like" cells peculiar to the RA synovium may be responsible for the homing and sustained survival of B cells in the synovium. However, in this study, we found that B cells spontaneously migrate beneath ordinary fibroblast-like synoviocytes (FLSs) and then experience prolonged survival. FLSs isolated from joints of patients with osteoarthritis also supported this activity, termed B-cell pseudoemperipolesis. We found that FLSs constitutively expressed the chemokine stromal cell-derived factor-1 (SDF-1), and that pertussis toxin or antibodies to the SDF-1 receptor (CXCR4) could inhibit B-cell pseudoemperipolesis. However, expression of SDF-1 is not sufficient, as dermal fibroblasts also expressed this chemokine but were unable to support B-cell pseudoemperipolesis unless previously stimulated with IL-4 to express CD106 (VCAM-1), a ligand for the alpha(4)beta(1) integrin, very-late-antigen-4 (VLA-4 or CD49d). Furthermore, mAb's specific for CD49d and CD106, or the synthetic CS1 fibronectin peptide, could inhibit B-cell pseudoemperipolesis. We conclude that ordinary FLSs can support B-cell pseudoemperipolesis via a mechanism dependent upon fibroblast expression of SDF-1 and CD106.

Citing Articles

Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis.

Wang Q, Ji J, Huang D, Gao C BME Front. 2025; 6:0102.

PMID: 40065832 PMC: 11893043. DOI: 10.34133/bmef.0102.


Tumor microenvironment as a novel therapeutic target for lymphoid leukemias.

Mousavi S, Nouri S, Sadeghipour A, Atashi A Ann Hematol. 2025; .

PMID: 39994019 DOI: 10.1007/s00277-025-06237-w.


Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications.

Xie G, Chen X, Gao Y, Yang M, Zhou S, Lu L Clin Rev Allergy Immunol. 2025; 68(1):18.

PMID: 39960645 PMC: 11832777. DOI: 10.1007/s12016-025-09021-w.


Applications of single-cell RNA sequencing in rheumatoid arthritis.

Figueiredo M Front Immunol. 2024; 15:1491318.

PMID: 39600707 PMC: 11588722. DOI: 10.3389/fimmu.2024.1491318.


Dihydroartemisinin Regulated the MMP-Mediated Cellular Microenvironment to Alleviate Rheumatoid Arthritis.

Guo Q, Wang Q, Chen J, Zhao M, Lu T, Guo Z Research (Wash D C). 2024; 7:0459.

PMID: 39257420 PMC: 11385568. DOI: 10.34133/research.0459.


References
1.
Hayashida K, Shimaoka Y, Ochi T, Lipsky P . Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol. 2000; 164(2):1110-6. DOI: 10.4049/jimmunol.164.2.1110. View

2.
Lindhout E, van Eijk M, van Pel M, Lindeman J, Dinant H, de Groot C . Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol. 1999; 162(10):5949-56. View

3.
Bowman E, Campbell J, Soler D, Dong Z, Manlongat N, Picarella D . Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med. 2000; 191(8):1303-18. PMC: 2193143. DOI: 10.1084/jem.191.8.1303. View

4.
Kroemer G, Reed J . Mitochondrial control of cell death. Nat Med. 2000; 6(5):513-9. DOI: 10.1038/74994. View

5.
Reparon-Schuijt C, van Esch W, van Kooten C, Rozier B, Levarht E, Breedveld F . Regulation of synovial B cell survival in rheumatoid arthritis by vascular cell adhesion molecule 1 (CD106) expressed on fibroblast-like synoviocytes. Arthritis Rheum. 2000; 43(5):1115-21. DOI: 10.1002/1529-0131(200005)43:5<1115::AID-ANR22>3.0.CO;2-A. View